BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10544324)

  • 1. Community rating and choice between traditional health insurance and managed care.
    Kifmann M
    Health Econ; 1999 Nov; 8(7):563-78. PubMed ID: 10544324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative health insurance schemes: a welfare comparison.
    Hansen BO; Keiding H
    J Health Econ; 2002 Sep; 21(5):739-56. PubMed ID: 12349880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community rating in health insurance and different benefit packages.
    Kifmann M
    J Health Econ; 2002 Sep; 21(5):719-37. PubMed ID: 12349879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumer choice among Mutual Healthcare Purchasers: a feasible option for China?
    Xu W; van de Ven WP
    Soc Sci Med; 2013 Nov; 96():277-84. PubMed ID: 23261255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worker demand for health insurance in the non-group market: a note on the calculation of welfare loss.
    Chernew M; Frick K; McLaughlin CG
    J Health Econ; 1997 Jun; 16(3):375-80. PubMed ID: 10169307
    [No Abstract]   [Full Text] [Related]  

  • 6. Consumer information surplus and adverse selection in competitive health insurance markets: an empirical study.
    van de Ven WP; van Vliet RC
    J Health Econ; 1995 Jun; 14(2):149-69. PubMed ID: 10154655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of government in health insurance markets with adverse selection.
    Feldman R; Escribano C; Pellisé L
    Health Econ; 1998 Dec; 7(8):659-70. PubMed ID: 9890328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managed competition in California's small-group insurance market.
    Buchmueller TC
    Health Aff (Millwood); 1997; 16(2):218-28. PubMed ID: 9086671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching costs, price sensitivity and health plan choice.
    Strombom BA; Buchmueller TC; Feldstein PJ
    J Health Econ; 2002 Jan; 21(1):89-116. PubMed ID: 11845927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How can the regulator show evidence of (no) risk selection in health insurance markets? Conceptual framework and empirical evidence.
    van de Ven WP; van Vliet RC; van Kleef RC
    Eur J Health Econ; 2017 Mar; 18(2):167-180. PubMed ID: 26837411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk segmentation: goal or problem?
    Feldman R; Dowd B
    J Health Econ; 2000 Jul; 19(4):499-512. PubMed ID: 11010237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report says managed care costs the same as traditional insurance.
    Wagner L
    Mod Healthc; 1993 Jul; 23(28):10-1. PubMed ID: 10126893
    [No Abstract]   [Full Text] [Related]  

  • 13. Consumer price sensitivity in Dutch health insurance.
    van Dijk M; Pomp M; Douven R; Laske-Aldershof T; Schut E; de Boer W; de Boo A
    Int J Health Care Finance Econ; 2008 Dec; 8(4):225-44. PubMed ID: 18709549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring adverse selection in managed health care.
    Frank RG; Glazer J; McGuire TG
    J Health Econ; 2000 Nov; 19(6):829-54. PubMed ID: 11186848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How will changes in health insurance tax policy and employer health plan contributions affect access to health care and health care costs?
    Marquis MS; Buchanan JL
    JAMA; 1994 Mar 23-30; 271(12):939-44. PubMed ID: 8120964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managed competition and consumer price sensitivity in social health insurance.
    Schut FT; Hassink WH
    J Health Econ; 2002 Nov; 21(6):1009-29. PubMed ID: 12475123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking health care costs.
    Strunk BC; Ginsburg PB; Gabel JR
    Health Aff (Millwood); 2001; Suppl Web Exclusives():W39-50. PubMed ID: 11911324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imperfect risk adjustment, risk preferences, and sorting in competitive health insurance markets.
    Layton TJ
    J Health Econ; 2017 Dec; 56():259-280. PubMed ID: 29248056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premium variation in the individual health insurance market.
    Herring B; Pauly MV
    Int J Health Care Finance Econ; 2001 Mar; 1(1):43-58. PubMed ID: 14626006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What can Europe learn from the managed care backlash in the United States?
    Duijmelinck D; van de Ven W
    Health Policy; 2016 May; 120(5):509-18. PubMed ID: 27055353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.